Once generic versions of medications are approved, prices drop. Under the current pricing structure set out by the ...

True, Novo Nordisk is making progress in this field. It recently earned approval for an oral formulation of Wegovy, which ...

The first data has emerged on the uptake of Novo Nordisk's new oral version of GLP-1 agonist weight-loss therapy Wegovy, with ...

Novo Nordisk stock rose 4% after the U.K. approved a higher 7.2mg Wegovy dose and early prescription data showed strong ...

Strive Specialities Inc., a major provider of compounded medicines, filed a federal lawsuit against pharmaceutical giants Eli ...

Nvidia and Eli Lilly unveiled a co-innovation AI Lab for drug discovery efforts. Nvidia announced a strategic collaboration ...

Eli Lilly is partnering with Nvidia to build an AI research lab. The drugmaker has made several AI moves in recent years. There are other reasons to buy the stock.